The MUHC's Distinguished Public Lecture Series Begins A Second Season

Main Category: Alzheimer's / Dementia
Also Included In: Diabetes;  Public Health;  Conferences
Article Date: 01 Oct 2007 - 12:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

"From Microscope to Stethoscope," the distinguished public lecture series organized by the Research Institute of the McGill University Health Centre (MUHC), is embarking on a second season. "Again this year, three of our most brilliant researchers invite you on a journey into a possible future, when current research has already turned into innovative treatments for patients," declared Dr. Arthur T. Porter, Director General of the MUHC. These lectures will give you a direct look at the intellectual vitality that fills our research laboratories and the enormous impact of this work on our daily lives.

Dr. Vassilios Papadopoulos, Director of the Research Institute of the MUHC, will open the lecture series on Wednesday, October 3, 2007 by sharing the hope that his current research may bring to patients suffering from Alzheimer's disease. His latest laboratory findings could lead to remarkable therapeutic advances and relieve the difficulties doctors currently have in terms of diagnosis and treatment.

Dr. Lawrence Rosenberg, a world expert in diabetes, will present the second lecture on Monday, November 7, 2007, followed by Dr. Ronald Olivenstein, MUHC Asthma Clinic Director, on Wednesday, December 3, 2007.

The lectures will take place at the Montreal General Hospital in Livingston Hall (Rom L6-500) starting at 7:30 p.m. Admission is free and anyone interested is welcome.

The speakers will take questions from audience members during a discussion period following each lecture.

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

The Research Institute of the McGill University Health Centre (RI MUHC) is a world-renowned biomedical and health-care hospital research centre. Located in Montreal, Quebec, the institute is the research arm of the MUHC, a university health center affiliated with the Faculty of Medicine at McGill University. The institute supports over 500 researchers, nearly 1000 graduate and post-doctoral students and operates more than 300 laboratories devoted to a broad spectrum of fundamental and clinical research. The Research Institute operates at the forefront of knowledge, innovation and technology and is inextricably linked to the clinical programs of the MUHC, ensuring that patients benefit directly from the latest research-based knowledge. For further details visit: http://www.muhc.ca/research.

The McGill University Health Centre (MUHC) is a comprehensive academic health institution with an international reputation for excellence in clinical programs, research and teaching. The MUHC is a merger of five teaching hospitals affiliated with the Faculty of Medicine at McGill University -- the Montreal Children's, Montreal General, Royal Victoria, and Montreal Neurological Hospitals, as well as the Montreal Chest Institute. Building on the tradition of medical leadership of the founding hospitals, the goal of the MUHC is to provide patient care based on the most advanced knowledge in the health care field, and to contribute to the development of new knowledge. http://www.muhc.ca/

Source: Isabelle Kling
McGill University Health Centre